lansoprazole has been researched along with Atherosclerosis in 2 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
Atherosclerosis: A thickening and loss of elasticity of the walls of ARTERIES that occurs with formation of ATHEROSCLEROTIC PLAQUES within the ARTERIAL INTIMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ma, Y | 1 |
| Li, S | 1 |
| Yang, H | 1 |
| Zhang, Y | 1 |
| Li, H | 1 |
| Zhou, L | 1 |
| Lin, J | 1 |
| Chen, Y | 1 |
| Hou, Y | 1 |
| Zhang, X | 1 |
| Liu, T | 1 |
| Zhou, X | 1 |
| Wang, Y | 1 |
| Aydemir, S | 1 |
| Eren, H | 1 |
| Tekin, IO | 1 |
| Harmandar, FA | 1 |
| Demircan, N | 1 |
| Cabuk, M | 1 |
1 trial available for lansoprazole and Atherosclerosis
| Article | Year |
|---|---|
Helicobacter pylori eradication lowers serum asymmetric dimethylarginine levels.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Arginine; Athero | 2010 |
1 other study available for lansoprazole and Atherosclerosis
| Article | Year |
|---|---|
Acid suppressants use and risk of atherosclerotic cardiovascular disease in middle-aged and older adults.
Topics: Aged; Antihypertensive Agents; Atherosclerosis; Cardiovascular Diseases; Histamine; Humans; Lansopra | 2022 |